FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 316:650-655 March 12, 1987 Number 11 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Although several studies have reported that the use of oral contraceptives decreases the risk of ovarian cancer, it is not clear whether the effect varies according to the oral-contraceptive formulation or the histologic type of cancer. To characterize this association more fully, we used data from a case-control study, the Cancer and Steroid Hormone Study. From 1980 to 1982, 546 women 20 to 54 years of age with ovarian cancer were enrolled from eight population-based cancer registries. The controls were 4228 women selected from the same areas. Women who had used oral contraceptives had a risk of epithelial ovarian cancer of 0.6 (95 percent confidence interval, 0.5 to 0.7) as compared with those who had never used them. This protective effect was seen in women who had used oral contraceptives for as little as three to six months, and it continued for 15 years after use ended; it was independent of the specific oral-contraceptive formulation and of the histologic type of epithelial ovarian cancer. (We could not adequately assess the association with nonepithelial ovarian cancers because of an insufficient number of cases.) We conclude that the use of oral contraceptives decreases the risk of epithelial ovarian cancer.

This article has been cited by other articles:

• Tworoger, S. S., Fairfield, K. M., Colditz, G. A., Rosner, B. A., Hankinson, S. E. (2007). Association of Oral Contraceptive Use, Other Contraceptive Methods, and Infertility with Ovarian Cancer Risk. Am J Epidemiol 166: 894-901 [Abstract] [Full Text]  
• Lurie, G., Thompson, P., McDuffie, K. E., Carney, M. E., Terada, K. Y., Goodman, M. T. (2007). Association of Estrogen and Progestin Potency of Oral Contraceptives With Ovarian Carcinoma Risk. Obstet Gynecol 109: 597-607 [Abstract] [Full Text]  
• Bhoola, S., Hoskins, W. J. (2006). Diagnosis and management of epithelial ovarian cancer.. Obstet Gynecol 107: 1399-1410 [Abstract] [Full Text]  
• Greer, J. B., Modugno, F., Allen, G. O., Ness, R. B. (2005). Short-Term Oral Contraceptive Use and the Risk of Epithelial Ovarian Cancer. Am J Epidemiol 162: 66-72 [Abstract] [Full Text]  
• Greer, J. B., Modugno, F., Allen, G. O., Ness, R. B. (2005). Androgenic Progestins in Oral Contraceptives and the Risk of Epithelial Ovarian Cancer. Obstet Gynecol 105: 731-740 [Abstract] [Full Text]  
• Pearce, C. L., Hirschhorn, J. N., Wu, A. H., Burtt, N. P., Stram, D. O., Young, S., Kolonel, L. N., Henderson, B. E., Altshuler, D., Pike, M. C. (2005). Clarifying the PROGINS Allele Association in Ovarian and Breast Cancer Risk: A Haplotype-Based Analysis. JNCI J Natl Cancer Inst 97: 51-59 [Abstract] [Full Text]  
• Modugno, F. (2004). Ovarian Cancer and Polymorphisms in the Androgen and Progesterone Receptor Genes: A HuGE Review. Am J Epidemiol 159: 319-335 [Abstract] [Full Text]  
• Zhang, Y., Coogan, P. F., Palmer, J. R., Strom, B. L., Rosenberg, L. (2004). Cigarette Smoking and Increased Risk of Mucinous Epithelial Ovarian Cancer. Am J Epidemiol 159: 133-139 [Abstract] [Full Text]  
• Tung, K.-H., Goodman, M. T., Wu, A. H., McDuffie, K., Wilkens, L. R., Kolonel, L. N., Nomura, A. M. Y., Terada, K. Y., Carney, M. E., Sobin, L. H. (2003). Reproductive Factors and Epithelial Ovarian Cancer Risk by Histologic Type:A Multiethnic Case-Control Study. Am J Epidemiol 158: 629-638 [Abstract] [Full Text]  
• Schumer, S. T., Cannistra, S. A. (2003). Granulosa Cell Tumor of the Ovary. JCO 21: 1180-1189 [Abstract] [Full Text]  
• Schouten, L. J., Goldbohm, R. A., van den Brandt, P. A. (2003). Height, Weight, Weight Change, and Ovarian Cancer Risk in the Netherlands Cohort Study on Diet and Cancer. Am J Epidemiol 157: 424-433 [Abstract] [Full Text]  
• Brewer, M. A., Johnson, K., Follen, M., Gershenson, D., Bast, R. Jr. (2003). Prevention of Ovarian Cancer: Intraepithelial Neoplasia. Clin. Cancer Res. 9: 20-30 [Abstract] [Full Text]  
• Rodriguez, C., Calle, E. E., Fakhrabadi-Shokoohi, D., Jacobs, E. J., Thun, M. J. (2002). Body Mass Index, Height, and the Risk of Ovarian Cancer Mortality in a Prospective Cohort of Postmenopausal Women. Cancer Epidemiol. Biomarkers Prev. 11: 822-828 [Abstract] [Full Text]  
• Riman, T., Dickman, P. W., Nilsson, S., Correia, N., Nordlinder, H., Magnusson, C. M., Persson, I. R. (2002). Risk Factors for Invasive Epithelial Ovarian Cancer: Results from a Swedish Case-Control Study. Am J Epidemiol 156: 363-373 [Abstract] [Full Text]  
• Fairfield, K. M., Willett, W. C., Rosner, B. A., Manson, J. E., Speizer, F. E., Hankinson, S. E. (2002). Obesity, Weight Gain, and Ovarian Cancer. Obstet Gynecol 100: 288-296 [Abstract] [Full Text]  
• Barnes, M. N., Grizzle, W. E., Grubbs, C. J., Partridge, E. E. (2002). Paradigms for Primary Prevention of Ovarian Carcinoma. CA Cancer J Clin 52: 216-225 [Abstract] [Full Text]  
• Davidson, N. E., Helzlsouer, K. J. (2002). Good News about Oral Contraceptives. NEJM 346: 2078-2079 [Full Text]  
• Riman, T., Dickman, P. W., Nilsson, S., Correia, N., Nordlinder, H., Magnusson, C. M., Weiderpass, E., Persson, I. R. (2002). Hormone Replacement Therapy and the Risk of Invasive Epithelial Ovarian Cancer in Swedish Women. JNCI J Natl Cancer Inst 94: 497-504 [Abstract] [Full Text]  
• Schildkraut, J. M., Calingaert, B., Marchbanks, P. A., Moorman, P. G., Rodriguez, G. C. (2002). Impact of Progestin and Estrogen Potency in Oral Contraceptives on Ovarian Cancer Risk. JNCI J Natl Cancer Inst 94: 32-38 [Abstract] [Full Text]  
• Rodriguez, G. C., Nagarsheth, N. P., Lee, K. L., Bentley, R. C., Walmer, D. K., Cline, M., Whitaker, R. S., Isner, P., Berchuck, A., Dodge, R. K., Hughes, C. L. (2002). Progestin-Induced Apoptosis in the Macaque Ovarian Epithelium: Differential Regulation of Transforming Growth Factor-{beta}. JNCI J Natl Cancer Inst 94: 50-60 [Abstract] [Full Text]  
• Mills, G. B. (2002). Mechanisms Underlying Chemoprevention of Ovarian Cancer. Clin. Cancer Res. 8: 7-10 [Abstract] [Full Text]  
• Prior, J. C., Kirkland, S. A., Joseph, L., Kreiger, N., Murray, T. M., Hanley, D. A., Adachi, J. D., Vigna, Y. M., Berger, C., Blondeau, L., Jackson, S. A., Tenenhouse, A., Group, f. (2001). Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study. CMAJ 165: 1023-1029 [Abstract] [Full Text]  
• Schildkraut, J. M., Cooper, G. S., Halabi, S., Calingaert, B., Hartge, P., Whittemore, A. S. (2001). Age at Natural Menopause and the Risk of Epithelial Ovarian Cancer. Obstet Gynecol 98: 85-90 [Abstract] [Full Text]  
• Ivarsson, K., Sundfeldt, K., Brannstrom, M., Hellberg, P., Janson, P. O. (2001). Diverse effects of FSH and LH on proliferation of human ovarian surface epithelial cells. Hum Reprod 16: 18-23 [Abstract] [Full Text]  
• Ness, R. B., Ann Grisso, J., Klapper, J., Schlesselman, J. J., Silberzweig, S., Vergona, R., Morgan, M., Wheeler, J. E., and the SHARE Study Group, (2000). Risk of Ovarian Cancer in Relation to Estrogen and Progestin Dose and Use Characteristics of Oral Contraceptives. Am J Epidemiol 152: 233-241 [Abstract] [Full Text]  
• Whiteman, D. C., Murphy, M. F. G., Cook, L. S., Cramer, D. W., Hartge, P., Marchbanks, P. A., Nasca, P. C., Ness, R. B., Purdie, D. M., Risch, H. A. (2000). Multiple Births and Risk of Epithelial Ovarian Cancer. JNCI J Natl Cancer Inst 92: 1172-1177 [Abstract] [Full Text]  
• MARCHBANKS, P. A., WILSON, H., BASTOS, E., CRAMER, D. W., SCHILDKRAUT, J. M., PETERSON, H. B. (2000). Cigarette Smoking and Epithelial Ovarian Cancer by Histologic Type. Obstet Gynecol 95: 255-260 [Abstract] [Full Text]  
• Ness, R. B., Cottreau, C. (1999). Possible Role of Ovarian Epithelial Inflammation in Ovarian Cancer. JNCI J Natl Cancer Inst 91: 1459-1467 [Abstract] [Full Text]  
• Salazar-Martinez, E., Lazcano-Ponce, E. C., Lira-Lira, G. G., los Rios, P. E.-D., Salmeron-Castro, J., Hernandez-Avila, M. (1999). Reproductive Factors of Ovarian and Endometrial Cancer Risk in a High Fertility Population in Mexico. Cancer Res. 59: 3658-3662 [Abstract] [Full Text]  
• Lebow, M. A. (1999). THE PILL AND THE PRESS: REPORTING RISK. Obstet Gynecol 93: 453-456 [Abstract] [Full Text]  
• Rodriguez, G. C., Walmer, D. K., Cline, M., Krigman, H., Lessey, B. A., Whitaker, R. S., Dodge, R., Hughes, C. L. (1998). Effect of Progestin on the Ovarian Epithelium of Macaques: Cancer Prevention Through Apoptosis?. Reproductive Sciences 5: 271-276 [Abstract]  
• Braverman, P. K., Strasburger, V. C. (1993). Contraception. CLIN PEDIATR 32: 725-734 [Abstract]  
• Baird, D. T., Glasier, A. F. (1993). Hormonal Contraception. NEJM 328: 1543-1549 [Full Text]  
• Morell, C. (1988). From Cycle to Syndrome and Back Again: A Social Work Response to PMS. Affilia 3: 10-22 [Abstract]